Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07046949Completed
Randomised, double-blind trial in Uterine Fibroids (UF), abnormal uterine bleeding (AUB) and uterine neoplasms (2 arms), sponsored by Yuri Semenyuk Rivne Regional Clinical Hospital. Primary endpoints: Pain level after surgery at 48 hours, Requirement of morphine for 24 hours at 48 hours and 1 more. Started Jul 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07046949.